SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-20-019193
Filing Date
2020-10-09
Accepted
2020-10-09 10:00:46
Documents
13
Period of Report
2020-10-08
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 36323
2 ex99-1.htm EX-99.1 16834
  Complete submission text file 0001493152-20-019193.txt   232575

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE vbiv-20201008.xsd EX-101.SCH 3195
4 XBRL LABEL FILE vbiv-20201008_lab.xml EX-101.LAB 34591
5 XBRL PRESENTATION FILE vbiv-20201008_pre.xml EX-101.PRE 22716
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3632
Mailing Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142
Business Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142 617-830-3031
VBI Vaccines Inc/BC (Filer) CIK: 0000764195 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37769 | Film No.: 201232333
SIC: 2834 Pharmaceutical Preparations